Structure and properties of pharmacologically active polymers
The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Abstract
Although the concept of using pharmacologically active macromolecular compounds as drugs is still regarded with much skepticism for both theoretical and practical reasons, interest in this field has grown in recent years because of the opportunity to take advantage of the specific properties of polymeric materials. For low molecular weight drugs, changes in structure often lead to a loss of specific activity. On the other hand, the properties of macromolecular drugs depend on the structure of the polymer used and this can be varied over a wide range by the incorporation of comonomer units, by the application of polymer‐analogous reactions, or by related structural changes. A new model is presented for pharmacologically active polymers which incorporates the possibility for continuous variation in (a) solubility and toxicity, (b) fixation and removal of active material, and (c) body distribution. Using the new model as a guide, examples of the synthesis and study of the biological activity of various macromolecular drugs are presented in order to emphasize the importance of this cooperative effort between polymer research and therapeutic problems.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The drug-polymer conjugates were introduced in the early work by Helmut Ringsdorf in 1970s to improve drug solubility, toxicity, and body biodistribution, which was followed by extensive studies on the development of drug-polymer conjugates [143, 144].”
From Polymeric micelles for the delivery of poorly soluble drugs: From nanoformulation to clinical approval. (2020) · cites this paper as [144]
Citations
Cites
de Duve, C., & Wattiaux, R. (1966) · Annual Review of Physiology · doi:10.1146/annurev.ph.28.030166.002251 · Cited by 3,033
De Duve, C., De Barsy, T., Poole, B., Trouet, A., Tulkens, P., & Van Hoof, F. (1974) · Biochemical Pharmacology · doi:10.1016/0006-2952(74)90174-9 · Cited by 1,901
Chang, T. M. S. (1964) · Science · doi:10.1126/science.146.3643.524 · Cited by 1,011
Lysosomes in Biology and Pathology
Lagunoff, D. (1974) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1974.03230160059035 · Cited by 887
AN EXAMINATION OF THE CYTOTOXIC EFFECTS OF SILICA ON MACROPHAGES
Allison, A. C., Harington, J. S., & Birbeck, M. (1966) · The Journal of Experimental Medicine · doi:10.1084/jem.124.2.141 · Cited by 871
FACTOR-VIII COMPLEX AND ENDOTHELIAL DAMAGE
Boneu, B., Abbal, M., Plante, J., & Bierme, R. (1975) · The Lancet · doi:10.1016/s0140-6736(75)92650-1 · Cited by 716
de Duve, C. (2008) · Novartis Foundation Symposia · doi:10.1002/9780470715314.ch1 · Cited by 473
DRUG-CARRIER POTENTIAL OF LIPOSOMES IN CANCER CHEMOTHERAPY
Gregoriadis, G., Swain, C. P., Wills, E. J., & Tavill, A. S. (1974) · The Lancet · doi:10.1016/s0140-6736(74)90682-5 · Cited by 401
Poly[N-(2-hydroxypropyl)methacrylamide]—I. Radical polymerization and copolymerization
Kopeček, J., & Baẑilová, H. (1973) · European Polymer Journal · doi:10.1016/0014-3057(73)90063-3 · Cited by 300
Ryser, H. J.-P. (1968) · Science · doi:10.1126/science.159.3813.390 · Cited by 288
Research works printed but not linked: 20
- Lee H., 1971, Handbook for Surgery and Artificial Organs
- Kabaiwanow W., 1972, Plaste Kaut., 19, 886
- Wessel W., 1971, Arzeim. Forsch., 21, 1468
- Ryser H. J. P., 1970, Proc. Fourth Int. Cong. Pharm., 3, 96
- 1965, Silikose Forsch., 6, 213
- Ferruti P., 1966, Med. Lav., 57, 481
- V.Hofmann dissertation University of Mainz 1975.
- Burger A., 1970, Medicinal Chemistry, 1185
- Donaruma L. G., 1974, Prog. Polym. Sci., 4, 18
- G.Franzmann dissertation University of Mainz 1975.
- H.Morawetzet al. in press.
- Ringsdorf H., 1967, Strahlentherapie, 132, 627
- Busch H., 1961, Cancer Res., 21, 271
- H.Ritter dissertation University of Mainz 1975.
- M.Przybylski dissertation University of Mainz 1975.
- Jacob S. W., 1971, Dimethylsulfoxide
- V.Hofmann H.Ringsdorf andG.Muacevic Makromol. Chem. in press.
- Jacques P. J., 1966, Rev. Quest. Sci., 27, 99
- Jacques P. J., 1969, Lysosomes in Biology and Pathology, 395
- Szekerke M., 1972, Neoplasma, 19, 211
Cited by
Items 501–600 of 1,000
Targeting and Intracellular Delivery of Drugs
Duncan, R. (2006) · Wiley-VCH eBooks · doi:10.1002/3527600906.mcb.200500014 · Cited by 24
Ouchi, T., Fujie, H., Jokei, S., Sakamoto, Y., Chikashita, H., Inoi, T., & Vogl, O. (1986) · Journal of Polymer Science Part A Polymer Chemistry · doi:10.1002/pola.1986.080240903 · Cited by 23
Benington, L. R., Rajan, G. P., Locher, C., & Lim, L. Y. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13111762 · Cited by 22
“Chronic wounds often have reduced FGF-2 concentrations, which may account for their poor rates of healing and revascularisation [10,11].”
BackgroundFrancini, N., Purdie, L., Alexander, C., Mantovani, G., & Spain, S. G. (2015) · Macromolecules · doi:10.1021/acs.macromol.5b00447 · Cited by 22
Polymer Micelles for Drug Delivery
Kim, S., & Park, K. (2010) · CRC Press eBooks · doi:10.1201/9781420087734-c19 · Cited by 27
Surface-Immobilized Biomolecules
Hoffman, A. S., & Hubbell, J. A. (2012) · Elsevier eBooks · doi:10.1016/b978-0-08-087780-8.00032-2 · Cited by 24
Syntheses and effectiveness of functional peptide-based RAFT agents
Chen, C., Kong, F., Wei, X., & Thang, S. H. (2017) · Chemical Communications · doi:10.1039/c7cc05316a · Cited by 22
Liao, J., Song, Y., Liu, C., Li, D., Zheng, H. S., & Lü, B. (2019) · Polymer Chemistry · doi:10.1039/c9py01105f · Cited by 23
Polymer conjugates for focal and targeted delivery of drugs
Polyak, D., Eldar‐Boock, A., Baabur‐Cohen, H., & Satchi‐Fainaro, R. (2013) · Polymers for Advanced Technologies · doi:10.1002/pat.3158 · Cited by 22
“On the basis of the Ringsdorf model,([1]) polymeric carriers, which can actively target the tumor vasculature by ligand-mediated interactions, can be used to improve the therapeutic index of chemotherapeutic agents by increasing the time of drug exposure to tumor vasculature and can thus enhance treatment potency.”
BackgroundKunz, P. C., Brückmann, N. E., & Spingler, B. (2006) · European Journal of Inorganic Chemistry · doi:10.1002/ejic.200600824 · Cited by 22
Recognition of Amphiphiles with Many Pendent Galactose Residues byRicinus communisAgglutinin
Kawaguchi, T., Tagawa, K., Fumiyo, S., Matsunaga, T., & Kitano, H. (1999) · Journal of Colloid and Interface Science · doi:10.1006/jcis.1998.5976 · Cited by 22
Biological applications of functionalised polymers—a review
Akelah, A. (1984) · Journal of Chemical Technology and Biotechnology Chemical Technology · doi:10.1002/jctb.5040340602 · Cited by 22
Lammers, T., Šubr, V., Ulbrich, K., Peschke, P., Huber, P. E., Hennink, W. E., Storm, G., & Kiessling, F. M. (2010) · Nanomedicine · doi:10.2217/nnm.10.130 · Cited by 21
Mella, M., & Izzo, L. (2010) · Polymer · doi:10.1016/j.polymer.2010.05.013 · Cited by 21
Nitric oxide-releasing polymeric furoxan conjugates
Wang, T., van der Vlies, A. J., Uyama, H., & Hasegawa, U. (2015) · Polymer Chemistry · doi:10.1039/c5py01335f · Cited by 21
Duret, D., Grassin, A., Henry, M., Jacquet, T., Thoreau, F., Denis‐Quanquin, S., Coll, J., Boturyn, D., Favier, A., & Charreyre, M. (2017) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.7b00362 · Cited by 21
Iacobazzi, R. M., Lopalco, A., Cutrignelli, A., Laquintana, V., Lopedota, A., Franco, M., & Denora, N. (2017) · ChemMedChem · doi:10.1002/cmdc.201700322 · Cited by 21
NF-κB hijacking theranostic Pt(ll) complex in cancer therapy
Zhu, Y., Zhang, M., Luo, L., Gill, M. R., Pace, C. D., Battaglia, G., Zhang, Q., Zhou, H., Wu, J., Tian, Y., et al. (2019) · Theranostics · doi:10.7150/thno.30886 · Cited by 22
Biopolymeric Prodrug Systems as Potential Antineoplastic Therapy
Chiş, A. A., Arseniu, A. M., Morgovan, C., Dobrea, C. M., Frum, A., Juncan, A. M., Butucă, A., Ghibu, S., Gligor, F. G., & Rus, L. L. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14091773 · Cited by 23
“This model was first proposed by Helmut Ringsdorf in 1975 [20,21].”
MethodRelative hydrophobicity of synthetic macromolecules
Zaslavsky, B. Y., Baevskii, A. V., Rogozhin, S. V., Gedrovich, A. V., Shishkov, A. V., Gasanov, A. A., & Masimov, A. A. (1984) · Journal of Chromatography A · doi:10.1016/s0021-9673(01)87735-9 · Cited by 21
Salem, A. B., Sautrey, G., Fontanay, S., Duval, R. E., & Regnouf‐de‐Vains, J. (2011) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2011.10.031 · Cited by 23
Paulus, F., Steinhilber, D., Welker, P., Mangoldt, D., Licha, K., Depner, H., Sigrist, S. J., & Haag, R. (2014) · Polymer Chemistry · doi:10.1039/c4py00430b · Cited by 21
Franzmann, G., & Ringsdorf, H. (1976) · Die Makromolekulare Chemie · doi:10.1002/macp.1976.021770823 · Cited by 21
Self-citationCuchelkar, V., & Kopeček, J. (2006) · CRC Press eBooks · doi:10.1201/9781420021677-11 · Cited by 21
Shah, S. S., Kulkarni, M. G., & Mashelkar, R. A. (1990) · Journal of Applied Polymer Science · doi:10.1002/app.1990.070410943 · Cited by 21
Hirano, T., Ringsdorf, H., & Zaharko, D. S. (1980) · PubMed · Cited by 21
Self-citationCammas‐Marion, S., & Kataoka, K. (1996) · Springer eBooks · doi:10.1007/978-94-009-0333-3_6 · Cited by 24
Green synthesis of plant-stabilized Au nanoparticles for the treatment of gastric carcinoma
Poorshamohammad, C., Liu, L., Cheng, X., Momtazi‐Borojeni, A. A., & Chai, J. (2022) · Arabian Journal of Chemistry · doi:10.1016/j.arabjc.2022.104386 · Cited by 20
Drug content on anticancer efficacy of self-assembling ketal-linked dextran-paclitaxel conjugates
Guo, T., Zhong, H., Li, X., Mu, J., Liu, T., Yu, N., Zhao, Y., Liang, X., & Guo, S. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.05.045 · Cited by 20
Hill, S. K., England, R., & Perrier, S. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.01.023 · Cited by 20
Nanoparticles: A Novel Approach to Target Tumors
Verma, G., Rajagopalan, M. D., Valluru, R., & Sridhar, K. A. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-52727-9.00007-8 · Cited by 23
From Biocompatible to Biodegradable: Poly(Ethylene Glycol)s with Predetermined Breaking Points
Dingels, C., & Frey, H. (2013) · Advances in polymer science · doi:10.1007/12_2013_235 · Cited by 20
“Polymeric carriers for low molecular weight drugs rely on Ringsdorf’s drug delivery concept [23], which describes the use of a multifunctional, biocompatible synthetic polymer to transport pharmacons along with targeting moieties.”
BackgroundCan, H. K., Doğan, A. L., Rzaev, Z. M. O., Üner, A., & Güner, A. (2006) · Journal of Applied Polymer Science · doi:10.1002/app.21834 · Cited by 20
Taylor, L. D., Kolesinski, H. S., Mehta, A. C., Locatell, L., & Larson, P. S. (1982) · Die Makromolekulare Chemie Rapid Communications · doi:10.1002/marc.1982.030031105 · Cited by 20
Controlled release of NSAIDs bound to polyacrylic carrier systems
Parejo, C., Gallardo, A., & Román, J. S. (1998) · Journal of Materials Science Materials in Medicine · doi:10.1023/a:1008935926154 · Cited by 20
Shiah, J.-G., Koňák, Č., Spikes, J. D., & ̆ek, J. ̆. K. (1998) · Drug Delivery · doi:10.3109/10717549809031387 · Cited by 20
PEGylation and aqueous solution behaviour of pH responsive poly(l-lysine iso-phthalamide)
Yue, Z., Eccleston, M., & Slater, N. K. H. (2005) · Polymer · doi:10.1016/j.polymer.2004.09.041 · Cited by 20
Poly(ethylene Oxide)-Modified Polyaspartamide–Ferrocene Conjugates
Meirim, M. G., Neuse, E. W., & Caldwell, G. A. (1997) · Journal of Inorganic and Organometallic Polymers and Materials · doi:10.1023/a:1021488110997 · Cited by 20
Functionalization of dextran: Incorporation of carboxy groups by O‐succinoylation
Arranz, F., Sánchez‐Chaves, M., & Ramírez, J. C. (1992) · Die Angewandte Makromolekulare Chemie · doi:10.1002/apmc.1992.051940107 · Cited by 20
DIAGNOSIS AND TREATMENT OF DISEASES BY USING METALLIC NANOPARTICLES-A REVIEWPreprint
Mughal, S. S. (2022) · doi:10.22541/au.166401168.84305772/v1 · Cited by 20
Kockelmann, J., Zentel, R., & Nuhn, L. (2023) · Macromolecular Chemistry and Physics · doi:10.1002/macp.202300199 · Cited by 19
Qiao, Y., Duan, X., Fan, L., Li, W., Wu, H., & Wang, Y. (2014) · Journal of Polymer Research · doi:10.1007/s10965-014-0397-4 · Cited by 19
Polymeric biomaterials and nanomedicines
Yang, J., & Kopec̆ek, J. (2015) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2015.05.012 · Cited by 19
An overview on the potential biomedical applications of polysaccharides
Rajalekshmy, G. P., Devi, L. L., Joseph, J., & Rekha, M. R. (2019) · Elsevier eBooks · doi:10.1016/b978-0-08-102555-0.00002-9 · Cited by 27
Nanoparticles characterization using the CAM assay
Intasa-ard, S., & Birault, A. (2019) · The Enzymes · doi:10.1016/bs.enz.2019.09.001 · Cited by 20
Hoffman, A. S., & Lai, J. J. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.05.013 · Cited by 19
“Professor Helmut Ringsdorf, a professor of synthetic organic polymer chemistry at the University of Mainz in Germany, authored an important article back in 1975 on the use of synthetic polymers as drug carriers [9].”
BackgroundFortuin, L., Leshabane, M., Pfukwa, R., Coertzen, D., Birkholtz, L., & Klumperman, B. (2020) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.0c01234 · Cited by 19
Feng, X., Chaikof, E. L., Absalon, C., Drummond, C., Taton, D., & Gnanou, Y. (2011) · Macromolecular Rapid Communications · doi:10.1002/marc.201100459 · Cited by 19
Qiu, N., Cai, L., Xie, D., Wang, G., Wu, W., Zhang, Y., Song, H., Yin, H., & Chen, L. (2010) · Biomedical Materials · doi:10.1088/1748-6041/5/6/065006 · Cited by 19
“In fact, polymer–drug conjugates emerged in the mid 1970s [20], and since then have become a fast-growing field.”
BackgroundTimofeevsky, S. L., Панарин, Е. Ф., Vinogradov, O. L., & Nezhentsev, M. V. (1996) · Pharmaceutical Research · doi:10.1023/a:1016069315423 · Cited by 19
Cleavable Linkers to Enhance Selectivity of Antibody-Targeted Therapy of Cancer
Kukis, D. L., Novak‐Hofer, I., & DeNardo, S. J. (2001) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/10849780152752065 · Cited by 19
Feasibility of polymer-drug conjugates for non-cancer applications
Natfji, A. A., Osborn, H. M. I., & Greco, F. (2017) · Current Opinion in Colloid & Interface Science · doi:10.1016/j.cocis.2017.07.004 · Cited by 19
Cancer Nanotechnology: Opportunities for Prevention, Diagnosis, and Therapy
Zeineldin, R., & Syoufjy, J. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-6646-2_1 · Cited by 22
Progress in the polymer-paclitaxel conjugate
Liu, Y., Khan, A. R., Du, X., Zhai, Y., Tan, H., & Zhai, G. (2019) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2019.101237 · Cited by 18
Randárová, E., Kudláčová, J., & Etrych, T. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.06.040 · Cited by 18
Strategies and Means for Drug Targeting: An Overview
Torchilin, V. P. (2002) · Springer eBooks · doi:10.1007/978-1-4757-4627-3_1 · Cited by 18
Wente, M. N., Kleeff, J. H., Büchler, M. W., Wanders, J., Cheverton, P., Langman, S., & Friess, H. (2005) · Investigational New Drugs · doi:10.1007/s10637-005-1442-2 · Cited by 18
“By using pharmacologically active polymers the development of macromolecular antitumor agents is ongoing since the first description in 1975 [38].”
BackgroundBioinspired polymers that control intracellular drug delivery
Hoffman, A. S., Stayton, P. S., Press, O. W., Murthy, N., Lackey, C. A., Cheung, C., Black, F. E., Campbell, J. S., Fausto, N., Kyriakides, T. R., et al. (2001) · Biotechnology and Bioprocess Engineering · doi:10.1007/bf02931981 · Cited by 18
“Ringsdorf first proposed the potential of synthetic polymers to serve as multifunctional delivery vehicles [12].”
BackgroundCHITOSAN MICROSPHERES FOR THE DELIVERY OF CHEMOTHERAPEUTIC AGENTS: PACLITAXEL AS A MODEL
Al-najjar, B. Y., & Hussain, S. A. (2017) · Asian Journal of Pharmaceutical and Clinical Research · doi:10.22159/ajpcr.2017.v10i8.18765 · Cited by 18
Shen, W., Xiantang, D., Feener, E. P., & Ryser, H. J. ‐. (1989) · Journal of Controlled Release · doi:10.1016/0168-3659(89)90020-5 · Cited by 18
Marre, A. D., & Schact, E. (1992) · Die Makromolekulare Chemie · doi:10.1002/macp.1992.021931208 · Cited by 18
Tailoring of macromolecule conjugates using reversed micelles as matrix microreactors
Kabanov, A. V., Levashov, A. V., Khrutskaya, M. M., & Kabanov, V. A. (1990) · Die Makromolekulare Chemie · doi:10.1002/macp.1990.021911129 · Cited by 18
Akashi, M., & Takemoto, K. (1990) · Advances in polymer science · doi:10.1007/3-540-52834-2_4 · Cited by 18
Kobayashi, S., Gros, L., Muacevic, G., & Ringsdorf, H. (1983) · Die Makromolekulare Chemie · doi:10.1002/macp.1983.021840413 · Cited by 18
Self-citationNew Polymeric and Oligomeric Matrices as Drug Carriers
Ferruti, P., Scapini, G., Rusconi, L., & Tanzi, M. C. (1983) · Springer eBooks · doi:10.1007/978-1-4615-7643-3_5 · Cited by 18
Antitumor Activity of Furanoallocolchicinoid-Chitosan Conjugate
Svirshchevskaya, E. V., Gracheva, Y. A., Kuznetsov, A. G., & Myrsikova, E. V. (2016) · Medicinal Chemistry · doi:10.4172/2161-0444.1000401 · Cited by 17
“Basing on Ringsdorf model multiple drug conjugates were developed.”
BackgroundInfluentialPawar, S. K., Mahajan, K., & Vavia, P. R. (2017) · AAPS PharmSciTech · doi:10.1208/s12249-017-0787-0 · Cited by 18
Abdelghafour, M. M., Deák, Á., Szabó, D., Dékány, I., Rovó, L., & Janovák, L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23126807 · Cited by 17
“According to Ringsdorf’s model [12], a polymeric prodrug mainly contains five components: polymeric backbone, spacer, drug, soluble agent, and targeting group.”
MethodAmino Acid-PEGylated Resveratrol and Its Influence on Solubility and the Controlled Release Behavior
Zhang, Y., Song, H., Shang, Z., Chen, A., Huang, D., Zhao, H., & Du, H. (2014) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b13-00863 · Cited by 17
Multifunktionelle Poly(ethylenglycole)
Obermeier, B., Wurm, F. R., Mangold, C., & Frey, H. (2011) · Angewandte Chemie · doi:10.1002/ange.201100027 · Cited by 17
Karim, K. J. A., Utama, R. H., Lu, H., & Stenzel, M. H. (2014) · Polymer Chemistry · doi:10.1039/c4py00802b · Cited by 18
Historical View of the Design and Development of Nanocarriers for Overcoming Biological Barriers
Alonso, M. J., & Couvreur, P. (2012) · Royal Society of Chemistry eBooks · doi:10.1039/9781849735292-00003 · Cited by 19
Therapeutic protein and drug imprinted nanostructures as controlled delivery tools
Yavuz, H., Çetin, K., Akgönüllü, S., Battal, D., & Denizli, A. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-813627-0.00012-0 · Cited by 21
Controlled release of pendant bioactive materials from acrylic polymer colloids
Scholsky, K. M., & Fitch, R. M. (1986) · Journal of Controlled Release · doi:10.1016/0168-3659(86)90070-2 · Cited by 17
Structure and properties of synthetic polymers of pharmacological and biomedical interest
Ferruti, P. (1981) · Die Makromolekulare Chemie · doi:10.1002/macp.1981.020051981101 · Cited by 17
Nuhn, L., Hartmann, S., Palitzsch, B., Gerlitzki, B., Schmitt, E., Zentel, R., & Kunz, H. (2013) · Angewandte Chemie · doi:10.1002/ange.201304212 · Cited by 16
Mahadik, N., Barron, G. A., Lin, P. K. T., & Thompson, C. J. (2024) · RSC Pharmaceutics · doi:10.1039/d3pm00075c · Cited by 17
Applications of Polymers in Parenteral Drug Delivery
Vhora, I., Khatri, N., & Misra, A. R. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819659-5.00008-2 · Cited by 23
“Ringsdorf introduced the idea of polymer drug conjugates (Ringsdorf, 1975).”
BackgroundPolymeric Micelles for siRNA Delivery
Pittella, F., & Kataoka, K. (2012) · Advances in delivery science and technology · doi:10.1007/978-1-4614-4744-3_8 · Cited by 18
Supramolecular Bioconjugates for Protein and Small Drug Delivery
Salmaso, S., Bersani, S., Scomparin, A., Mastrotto, F., & Caliceti, P. (2010) · Israel Journal of Chemistry · doi:10.1002/ijch.201000022 · Cited by 16
Polymer Therapeutics: Design, Application, and Pharmacokinetics
Aderibigbe, B. A., & Mukaya, H. E. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-52727-9.00003-0 · Cited by 16
Karakuş, G., Can, H. K., & Yağlıoğlu, A. Ş. (2020) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2020.127989 · Cited by 16
Liver-targeted polymeric prodrugs of 8-aminoquinolines for malaria radical cure
Srinivasan, S., Roy, D., Chavas, T. E. J., Vlaskin, V. A., Ho, D., Pottenger, A. E., LeGuyader, C. L. M., Maktabi, M., Strauch, P., Jackson, C. L., et al. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.12.046 · Cited by 16
Multifunctional Water-Soluble Polymers for Drug Delivery
Pan, H., & Kopec̆ek, J. (2008) · Fundamental biomedical technologies · doi:10.1007/978-0-387-76554-9_4 · Cited by 17
Neuse, E. W., Mphephu, N., Netshifhefhe, H. M., & Johnson, M. T. (2002) · Polymers for Advanced Technologies · doi:10.1002/pat.241 · Cited by 16
Soo, P. L., Dunne, M., Liu, J., & Allen, C. J. (2008) · Springer eBooks · doi:10.1007/978-0-387-77668-2_12 · Cited by 17
Covalently-controlled drug delivery via therapeutic methacrylic tissue adhesives
Wright, Z. M., Holt, B. D., & Sydlik, S. A. (2017) · Journal of Materials Chemistry B · doi:10.1039/c7tb01151b · Cited by 17
Ouchi, T., Hagita, K., Kwashima, M., Inoi, T., & Tashiro, T. (1988) · Journal of Controlled Release · doi:10.1016/0168-3659(88)90040-5 · Cited by 16
CRITICAL REVIEW IN PHARMACEUTICAL SCIENCES
publisher, P. E. (2014) · ADVANCED SCIENCES INDEX · Cited by 16
Design of Polymer‐Drug Conjugates
Kopec̆ek, J., & Kopečková, P. (2011) · Wiley eBooks · doi:10.1002/9783527634057.ch17 · Cited by 15
Kim, K., Kim, T., Choi, J. H., Lee, J. Y., Hah, S. S., Yoo, H. O., Hwang, S. S., Ryu, K. N., Kim, H. J., & Kim, J. (2010) · Macromolecular Chemistry and Physics · doi:10.1002/macp.200900528 · Cited by 15
Hexanoate‐Cucurbit[7]uril: Highly Soluble with Controlled Release Ability
Chen, H., Zhang, J., Yu, Q., Chen, Y., & Tan, Y. (2020) · Chemistry - A European Journal · doi:10.1002/chem.202001959 · Cited by 15
Chitosan and its derivatives as self-assembled systems for drug delivery
(2014) · Elsevier eBooks · doi:10.1016/b978-1-907568-45-9.00003-2 · Cited by 22
Stepping Further from Coupling Tools: Development of Functional Polymers via the Biginelli Reaction
Ma, Z., Wang, B., & Tao, L. (2022) · Molecules · doi:10.3390/molecules27227886 · Cited by 16
Nanotechnology for Biomedical Applications
Pasika, S. R., Bulusu, R., Rao, B. V. K., Kommineni, N., Bolla, P. K., Kala, S. G., & Godugu, C. (2023) · Springer eBooks · doi:10.1007/978-981-19-7963-7_11 · Cited by 18
Abdellaoui, K., Boustta, M., Morjani, H., Manfait, M., & Vert, M. (1998) · Journal of drug targeting · doi:10.3109/10611869808995874 · Cited by 15
Kim, K., Choi, S.-Y., Jeon, H. J., Lee, J. Y., Choo, D. J., Kim, J., Kang, Y. S., & Yoo, H. O. (2008) · Macromolecular Research · doi:10.1007/bf03218847 · Cited by 15
Bioactive Albumin-Based Carriers for Tumour Chemotherapy
Shahzad, Y., Khan, I. U., Hussain, T., Alamgeer, Serra, C. A., Rizvi, S. A. A., Gerber, M., & du Plessis, J. (2014) · Current Cancer Drug Targets · doi:10.2174/1568009614666141028100640 · Cited by 16
“15 nano-encapsulation of chemotherapeutic drugs, because most drugs show high binding properties, and due to these particles being biodegradable, easy to prepare and reproducible [67].”
BackgroundMadsen, J., Madden, G., Themistou, E., Warren, N. J., & Armes, S. P. (2018) · Polymer Chemistry · doi:10.1039/c8py00111a · Cited by 17
Gautier, S., Boustta, M., & Vert, M. (1997) · Journal of Bioactive and Compatible Polymers · doi:10.1177/088391159701200201 · Cited by 16
Metadata
- Authors
- Ringsdorf, H.
- Affiliations
- Johannes Gutenberg University Mainz (DE)
- Corresponding author
- Ringsdorf, Helmut
- Venue
- Journal of Polymer Science: Polymer Symposia
- Publisher
- Wiley
- Published
- 1975-01
- Volume
- 51
- Issue
- 1
- Pages
- 135-153
- ISSN
- 0360-8905 (ISSN-L)
- 1936-0959
- OpenAlex
- W2098279377
- Cited by
- 1,094
- References
- 63
- Citations by year
- 2026: 8 · 2025: 10 · 2024: 34 · 2023: 35 · 2022: 30 · 2021: 35 · 2020: 50 · 2019: 36 · 2018: 29 · 2017: 46 · 2016: 45 · 2015: 47 · 2014: 55 · 2013: 43 · 2012: 48
- FWCI
- 6.78
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Polymer Science Polymer Symposia (publishedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Physical Sciences › Chemistry › Organic Chemistry › Advanced Polymer Synthesis and Characterization
- Physical Sciences › Materials Science › Biomaterials › Hydrogels: synthesis, properties, applications
- Keywords
- macromolecular drugs, comonomer incorporation, polymer-analogous reactions, solubility, toxicity, body distribution, polymer synthesis, biological activity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.